Last month we wrote about monoclonal antibody treatments (mAbs) and the critical role they play in preventing hospitalizations amid the constantly shifting COVID-19 landscape of variants and hot spots. Most recently, we’re learning where mAbs are most effective given rising rates of variants in particular regions. In areas,...
As we continue to navigate COVID-19, we’re excited to see more and more people receive the vaccine and celebrate a Food and Drug Administration (FDA) approved treatment for COVID-19 — monoclonal antibody treatments. A new treatment presents new questions. Monoclonal antibody treatments are typically used...
It has been roughly one year since the United States declared a national emergency in response to the COVID-19 pandemic. Our efforts to social distance, wear masks, and stay home whenever possible have contained the virus as best we can. However, these efforts only go...